Cellular Bioavailability of Peptide Nucleic Acids (PNAs) Conjugated to Cell Penetrating Peptides

Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines

Volumn , Issue , 2009, Pages 305-338

  Shiraishi, Takehiko ^a,b   Nielsen, Peter E ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Auxiliary agents; Cell penetrating peptides (CPPs) from functional domains of naturally occurring proteins; Cellular bioavailability of peptide nucleic acids (PNAs) conjugated to cell penetrating peptides; Cellular uptake versus bioavailability; Endosome disruptive agents; Peptide Nucleic Acids (PNAs); PNA peptide conjugates entering cells via endosomal pathway

Indexed keywords

EID: 84856888225     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470688397.ch16     Document Type: Chapter

References (64)

1. Nielsen, P.E., Egholm, M., Berg, R.H. and Buchardt, O. (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science, 254, 1497-1500.
2. Lundin, K.E., Good, L., Stromberg, R. et al. (2006) Biological activity and biotechnological aspects of peptide nucleic acid. Adv. Genet., 56, 1-51.
3. Derossi, D., Joliot, A.H., Chassaing, G. and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem., 269, 10444-10450.
4. Fawell, S., Seery, J., Daikh, Y. et al. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA, 91, 664-668.
5. Morris, M.C., Deshayes, S., Heitz, F. and Divita, G. (2008) Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol. Cell, 100, 201-217.
6. Wender, P.A., Mitchell, D.J., Pattabiraman, K. et al. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporter. Proc. Natl. Acad. Sci USA, 97, 13 003-13 008.
7. Fotin-Mleczek, M., Fischer, R. and Brock, R. (2005) Endocytosis and cationic cell-penetrating peptides-a merger of concepts and methods. Curr. Pharm. Des., 11, 3613-3628.
8. Fuchs, S.M. and Raines, R.T. (2004) Pathway for polyarginine entry into mammalian cells. Biochemistry, 43, 2438-2444.
9. Richard, J.P., Melikov, K., Vives, E. et al. (2003) A reevaluation of the mechanism of cellular uptake. J. Biol. Chem., 278, 585-590.
10. Kang, S.H., Cho, M.J. and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry, 37, 6235-6239.
11. Hu, J. and Corey, D.R. (2007) Inhibiting gene expression with Peptide Nucleic Acid (PNA)-peptide conjugates that target chromosomal DNA. Biochemistry, 46, 7581-7589.
12. Koppelhus, U., Shiraishi, T., Zachar, V. et al. (2008) Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain. Bioconjug. Chem., 19, 1526-1534.
13. Turner, J.J., Ivanova, G.D., Verbeure, B. et al. (2005) Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Res., 33, 6837-6849.
14. Abes, S., Moulton, H., Turner, J. et al. (2007) Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem. Soc. Trans., 35, 53-55.
15. Fabani, M.M. and Gait, M.J. (2008) miR-122 targeting with LNA/2 ′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA, 14, 336-346.
16. Gros, E., Deshayes, S., Morris, M.C. et al. (2006) A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim. Biophys. Acta, 1758, 384-393.
17. Morris, M.C., Gros, E., drian-Herrada, G. et al. (2007) A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res., 35, e49.
18. Bendifallah, N., Rasmussen, F.W., Zachar, V. et al. (2006) Peptides (CPPs) as vehicles for intracellular delivery of antisense Peptide Nucleic Acid (PNA). Bioconj. Chem., 17, 750-758.
19. El-Andaloussi, S., Johansson, H.J., Holm, T. and Langel, L. (2007) A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol. Ther., 15, 1820-1826.
20. Faridani, O.R., Nikravesh, A., Pandey, D.P. et al. (2006) Competitive inhibition of natural antisense Sok-RNA interactions activates Hok-mediated cell killing in Escherichia coli. Nucleic Acids Res., 34, 5915-5922.
21. Good, L., Awasthi, S.K., Dryselius, R. et al. (2001) Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol., 19, 360-364.
22. Kurupati, P., Tan, K.S., Kumarasinghe, G. and Poh, C.L. (2007) Inhibition of gene expression and growth by Antisense Peptide Nucleic Acids in a multiresistant {beta}-lactamase-producing klebsiella pneumoniae strain. Antimicrob. Agents Chemother., 51, 805-811.
23. Maier, M.A., Esau, C.C., Siwkowski, A.M. et al. (2006) Evaluation of basic amphipathic peptides for cellular delivery of antisense peptide nucleic acids. J. Med. Chem., 49, 2534-2542.
24. Nekhotiaeva, N., Awasthi, S.K., Nielsen, P.E. and Good, L. (2004) Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol. Ther., 10, 652-659.
25. Nikravesh, A., Dryselius, R., Faridani, O.R. et al. (2007) Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect. Mol. Ther., 15, 1537-1542.
26. Pritz, S., Wolf, Y., Kraetke, O. et al. (2007) Synthesis of biologically active peptide nucleic acid-peptide conjugates by sortase-mediated ligation. J. Org. Chem., 72, 3909-3912.
27. Shiraishi, T., Pankratova, S. and Nielsen, P.E. (2005) Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. Chem. Biol., 12, 923-929.
28. Wolf, Y., Pritz, S., Abes, S. et al. (2006) Structural remequirents for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides. Biochemistry, 45, 14 944-14 954.
29. Abes, S., Turner, J.J., Ivanova, G.D. et al. (2007) Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Res., 35, 4495-4502.
30. Bøe, S. and Hovig, E. (2006) Photochemically induced gene silencing using PNA-peptide conjugates. Oligonucleotides, 16, 145-157.
31. Resina, S., Abes, S., Turner, J.J. et al. (2007) Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides. Int. J. Pharm., 344, 96-102.
32. Yin, H., Lu, Q. and Wood, M. (2008) Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol. Ther., 16, 38-45.
33. Boffa, L.C., Cutrona, G., Cilli, M. et al. (2007) Inhibition of Burkitt ' s lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc. Cancer Gene Ther., 14, 220-226.
34. Rasmussen, F.W., Bendifallah, N., Zachar, V. et al. (2006) Evaluation of transfection protocols for unmodified and modified Peptide Nucleic Acid (PNA) oligomers. Oligonucleotides, 16, 43-57.
35. Robaczewska, M., Narayan, R., Seigneres, B. et al. (2005) Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA). J. Hepatol., 42, 180-187.
36. Fletcher, S., Honeyman, K., Fall, A.M. et al. (2006) Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. J. Gene Med., 8, 207-216.
37. El-Andaloussi, S., Johansson, H.J., Lundberg, P. and Langel, L. (2006) Induction of splice correction by cell-penetrating peptide nucleic acids. J. Gene Med., 8, 1262-1273.
38. Ganguly, S., Chaubey, B., Tripathi, S. et al. (2008) Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element. Oligonucleotides, 18, 277-286.
39. Koppelhus, U., Awasthi, S.K., Zachar, V. et al. (2002) Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev., 12, 51-63.
40. Villa, R., Folini, M., Lualdi, S. et al. (2000) Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells. FEBS Lett., 473, 241-248.
41. Dragulescu-Andrasi, A., Rapireddy, S., He, G.B. et al. (2006) Cell-permeable peptide nucleic acid designed to bind to the 5 ′-untranslated region of E-cadherin transcript induces potent and sequence-specific antisense effects. J. Am. Chem. Soc., 128, 16 104-16 112.
42. Nielsen, P.E. and Shiraishi, T. (2006) Improving the bioavailability of PNA-peptide conjugates. Pept. Sci., 43, 219.
43. Folini, M., Bandiera, R., Millo, E. et al. (2007) Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells. Cell Prolif., 40, 905-920.
44. Segura, J., Fillat, C., Andreu, D. et al. (2007) Monitoring gene therapy by external imaging of mRNA: pilot study on murine erythropoietin. Ther. Drug Monit., 29, 612-618.
45. Su, W., Mishra, R., Pfeuffer, J. et al. (2007) Synthesis and cellular uptake of a MR contrast agent coupled to an antisense peptide nucleic acid-cell-penetrating peptide conjugate. Contrast Media Mol. Imaging, 2, 42-49.
46. Tyagi, P., Banerjee, R., Basu, S. et al. (2006) Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates. Mol. Pharm., 3, 398-406.
47. Bárány-Wallje, E., Gaur, J., Lundberg, P. et al. (2007) Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo. FEBS Lett., 581, 2389-2393.
48. Kaihatsu, K., Huffman, K.E. and Corey, D.R. (2004) Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates. Biochemistry, 43, 14 340-14 347.
49. Kilk, K., Elmquist, A., Saar, K. et al. (2004) Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA. Neuropeptides, 38, 316-324.
50. Doyle, D.F., Braasch, D.A., Simmons, C.G. et al. (2001) Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry, 40, 53-64.
51. Shiraishi, T., Hamzavi, R. and Nielsen, P.E. (2008) Subnanomolar antisense activity of phosphonatepeptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells. Nucleic Acids Res., 36, 4424-4432.
52. Abes, S., Williams, D., Prevot, P. et al. (2006) Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates. J. Control. Release, 110, 595-604.
53. Shiraishi, T. and Nielsen, P.E. (2006) Enhanced delivery of cell-pepetrating peptide-peptide nucleic acid conjugates by endosomal disruption. Nat. Protoc., 1, 633-636.
54. Hogset, A., Prasmickaite, L., Hellum, M. et al. (2002) Photochemical transfection: a technology for efficient light-directed gene delivery. Somat. Cell Mol. Genet., 27, 97-113.
55. Hogset, A., Prasmickaite, L., Engesaeter, B.O. et al. (2003) Light directed gene transfer by photochemical internalisation. Curr. Gene Ther., 3, 89-112.
56. Shiraishi, T. and Nielsen, P.E. (2006) Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates. FEBS Lett., 580, 1451-1456.
57. Boules, M., Williams, K., Gollatz, E. et al. (2004) Down-regulation of amyloid precursor protein by peptide nucleic acid in vivo. J. Mol. Neurosci., 24, 123-128.
58. Efimov, V.A., Birikh, K.R., Staroverov, D.B. et al. (2006) Hydroxyproline-based DNA mimics provide an efficient gene silencing in vitro and in vivo. Nucleic Acids Res., 34, 2247-2257.
59. Fraser, G.L., Holmgren, J., Clarke, P.B.S. and Wahlestedt, C. (2000) Antisense inhibition of .delta.-opioid receptor gene function in vivo by peptide nucleic acids. Mol. Pharmacol., 57, 725-731.
60. McMahon, B.M., Stewart, J.A., Bitner, M.D. et al. (2002) Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. Life Sci., 71, 325-337.
61. Pooga, M., Soomets, U., H ä llbrink, M.H. et al. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol., 16, 857-861.
62. Sazani, P., Gemignani, F., Kang, S.H. et al. (2002) Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol., 20, 1228-1233.
63. Tyler, B.M., McCormick, D.J., Hoshall, C.V. et al. (1998) Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Lett., 421, 280-284.
64. Sazani, P., Gemignani, F., Kang, S.H. et al. (2002) Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol., 20, 1228-1233.